Overview of Q1/24 Performance The primary challenges faced by orthopedic companies in Q1/24 were related to selling day headwinds and tough comparable periods (comps) from Q1/23, which was a notably strong quarter. Despite these hurdles, the leading companies still managed to post robust growth, though with varying degrees of success....
